The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2019-01-22
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT03811678
- Locations
- 🇨🇳
the First Hospital of Jilin University, Changchun, Jilin, China
Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2022-06-22
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 158
- Registration Number
- NCT03758287
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 105
- Registration Number
- NCT03673696
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT03663686
- Locations
- 🇨🇳
Beijing shijitan hospital, Beijing, Beijing, China
A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects
- First Posted Date
- 2018-09-07
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT03662568
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2019-04-04
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 99
- Registration Number
- NCT03655873
- Locations
- 🇨🇳
First Hospital of Jilin University, Changchun, Jilin, China
The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT03638076
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
- First Posted Date
- 2018-04-19
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 55
- Registration Number
- NCT03502902
- Locations
- 🇺🇸
Covance Clinical Research Unit, Inc., Daytona Beach, Florida, United States
Phase 3 Study of Yimitasvir Phosphate Capsules
- First Posted Date
- 2018-04-03
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 362
- Registration Number
- NCT03487107
- Locations
- 🇨🇳
Beijing Friendship Hospital，Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing YouAn Hospital,Capital Medical University, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects
- First Posted Date
- 2018-03-12
- Last Posted Date
- 2018-03-12
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT03462173
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China